Yu, Jiayi
He, Qiang
Yan, Yuting
Liu, Kuntong
Xie, Rong
Ma, Ji
Wang, Liang
Funding for this research was provided by:
the Zhongguancun Precision Medicine Foundation's "New Life" Charity Project (GXZDH48)
the CSCO-Hengrui Oncology Research Fund (Y-HR2020QN-0175)
the China Health & Medical Development Foundation (chmdf2025-xrky04-09)
Article History
Received: 28 November 2025
Accepted: 30 January 2026
First Online: 10 February 2026
Declarations
:
: This study was approved by the Ethics Committee of Cancer Hospital of Shandong First Medical University (Approval No. SDTHEC2024006130) and Shengli Oilfield Central Hospital (Approval No. YXLL202504501). Given the retrospective design of the study and the use of archived specimens, the ethics committee waived the requirement for written informed consent.
: The authors declare no competing interests.